Happy for you kutaiba You shine as usual We will do reunion meeting ACG

Another small step toward the GI. I am lucky to have such great colleagues Shahem Abbarh, MBBS, MRCP(UK) Mhd Kutaiba Albuni, M.D Thanks ACG for this recognition.

Such a good game New hobby &

Over the past few days, I've had some remarkable moments that have taught me some lessons: always take photos and savor every moment. Laugh freely and never hesitate to show appreciation for the people who are a part of your life. lastly remember this life is extremely short.

Presenting abstracts & enjoying our time at OGS, meeting my colleagues from UT and my dear Syrian friends 😊 Ohio Gastroenterology Society University of Toledo Internal Medicine Residency #SyrianFriends Shahem Abbarh, MBBS, MRCP(UK) Mhd Kutaiba Albuni, M.D Yusuf Hallak

Very happy for my dear friends Naim and Hadeel on the arrival of their beautiful baby boy, Noah! Wishing him a lifetime filled with good health. May God bring warmth and joy to your family. I have no doubt you both will be amazing parents Naim Battikh, MD Hadeel

Such an amazing and memorable day

Feeling belonged to this family University of Toledo Internal Medicine Residency

From the day one, we have stood together as Syrians, sharing struggles, facing hardships, walking the same paths, and celebrating our achievements, Today, we celebrate the happiest day of ((a free Syria)) Here’s to a future we’ve all dreamed of, proudly call home. 💚💚💚💚💚💚

Another small step Enjoyed the event and meeting IBD leaders.

A great opportunity to attend #CCCongress25 to present our abstracts with Shahem Abbarh, MBBS, MRCP(UK) and connect with leaders in this growing field. Grateful for the insights and great people who i met here, loving the San Francisco vibes! #IBD #AGA #MedTwitter

hrilled to see our team's hard work pay off such a massive achievement! Grateful to all friends, fellows, and mentors across the U.S. who collaborated to reach our goals. Huge shoutout to the IM-UTMC group for their incredible effort! #DDW2025 #GITwitter University of Toledo Internal Medicine Residency Gastroenterology

#DDW2025 🥊Real-world outcomes RISA vs OTHER at yr2 in #Crohns Digestive Disease Week 🥊RISA vs UST: 👍🏼RISA ✅At 12 mos:⬇️PO predn use & 🏥 ✅At 24 mos: ⬇️Odds of major SB & colon✂️ 🥊RISA vs TNFi ✅At 12 months & 24 months: ⬇️Odds of PO predn on RISA

#DDW2025 was straight fire! Our Toledo squad crushed it, and bumping into Syrian friends felt like a mini reunion with extra hummus. Huge shoutout to all the brains and mentors behind the magic, we actually pulled it off! San Diego, you’re officially top tier (your tacos too).

📢 Just out! Our meta-analysis comparing adalimumab vs infliximab in perianal Crohn’s disease (6 studies, n=590): No significant difference in clinical or radiologic healing.✅ Adalimumab is non-inferior to infliximab! Huge thanks to David T. Rubin, MD (Dr. David T. Rubin)! #IBD #Crohns

Newly published In IBD, choosing between anti-TNF and anti-IL-12/23 is like picking your fighter turns out, both pack a punch. 💥 New data suggests anti-IL-12/23 holds its own, even in TNF-naïve patients. #IBD #GI #MedTwitter 📖 karger.com/iid/article/do…” Miguel Regueiro

My final masterpiece from my time in Qatar After 3 months of battling relentless constipation and a whole lot of trouble (and no, the patient wasn't talking about her symptoms 😅) Patient: 1 💩 | Fecaloma: 0 Treatment: Laxatives, IV fluids, and a swift goodbye to aripiprazole

Despite all the challenges, your resilience shines through. Wishing you continued success bro.. you’re destined to achieve great things as usual 💪🏻